Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMJGleeson Regulatory News (GLE)

Share Price Information for MJGleeson (GLE)

Share Price is delayed by 15 minutes
Get Live Data
245.00    0.00 (0.00%)
Bid:
245.00
Ask:
250.00
Spread: 5.00 (2.041%)
Market Cap: £142.92m
GLE Live PriceLast checked at - London Stock Exchange

Intraday MJGleeson Share Chart

Board Changes

12 Dec 2008 11:00

RNS Number : 0326K
Gleeson(M J)Group PLC
12 December 2008
 



12 December 2008

M J GLEESON GROUP PLC

Board Changes

Resignation of Paul Wallwork as Group Chief Executive

Gleeson (GLE.L), the urban regeneration and strategic land specialist, announces the resignation of Paul Wallwork as Group Chief Executive with effect from 31 December 2008

Paul Wallwork, ACA, BA (Hons), 46, was appointed to the Board in January 2006 as Group Finance Director. He was appointed Group Chief Executive in January 2007 having previously served as Interim Group Chief Executive since July 2006. He previously held senior financial and management roles with Inchcape plc and senior financial roles with Brent International plc.

Dermot Gleeson, Non-executive Chairman, stated "I would like to thank Paul for his strong and energetic leadership of the Gleeson Group through an extremely challenging period. He has ensured that the Group is well placed to meet the tough challenges faced by all housebuilders in the current market conditions."

Appointment of Group Chief Executive

Gleeson is pleased to announce the appointment as Group Chief Executive, with effect from 1 January 2009, of Chris Holt who, since 1 May 2007, has been Group Finance Director and prior to that held the position of Interim Group Finance Director from August 2006.

Nicholas Christopher Holt, BSc, MBA, CIMA, 57, has obtained a wealth of financial and management experience at senior level with internationally renowned businesses, namely Foster Wheeler (1987-2005) and Bechtel (1975-87). 

Dermot Gleesonstated "As Group Finance Director, Chris has made a hugely important contribution to the successful restructuring of the Group, and his skills and experience mean that he is very well equipped to provide the effective leadership that Gleeson will continue to need in an exceptionally difficult economic environment."

Appointment of Group Finance Director

To replace Chris Holt, Gleeson is pleased to announce the appointment of Alan Martin as Group Finance Director with effect from 1 January 2009. Alan is currently Group Financial Controller, a position he has held since November 2006.

Alan Martin, BSc (Hons), ACA, 42, qualified as a Chartered Accountant in 1990, following which he joined Price Waterhouse where he specialised in corporate recovery in both London and SydneyAustralia. Assignments included secondment as Advisor to National Australia Bank. In 2000, he joined Psion PLC, where he held a number of senior management roles, the most recent being Group Financial Controller.

Alan Martin has held no directorship in any other publicly quoted company at any time in the previous five years and there are no details to be disclosed under paragraph 9.6.13 R of the Listing Rules.

Dermot Gleeson stated "I am delighted that Alan has joined the Board to which he has the potential to make an extremely valuable contribution." 

Enquiries:

M J Gleeson Group plc 01252 360300

Chris Holt (Group Chief Executive, Designate)

Alan Martin (Group Finance Director, Designate)

Bankside Consultants Limited

Charles Ponsonby  020 7367 8851

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKBKNKBDDFBD
Date   Source Headline
2nd Jun 20267:00 amRNSBoard Committee Changes
7th May 20264:36 pmRNSDirector/PDMR Shareholding
7th May 20262:49 pmRNSDirector/PDMR Shareholding
1st May 20267:00 amRNSTrading Update
23rd Apr 20267:00 amRNSNotice of Trading Updates and FY2026 Results
14th Apr 20269:34 amRNSDirector/PDMR Shareholding
14th Apr 20269:33 amRNSDirector/PDMR Shareholding
6th Mar 20263:19 pmRNSDirector/PDMR Shareholding
2nd Mar 20264:04 pmRNSHolding(s) in Company
11th Feb 20267:00 amRNSResults for the half year ended 31 December 2025
9th Feb 202610:47 amRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNS-RPresentation of HY Results on Engage Investor
16th Jan 20267:00 amRNSTrading Update and Notice of Results
6th Jan 20264:40 pmRNSDirector/PDMR Shareholding
9th Dec 202511:31 amRNSDirector/PDMR Shareholding
25th Nov 20251:01 pmRNSDirector/PDMR Shareholding
20th Nov 20253:25 pmRNSHolding(s) in Company
14th Nov 20252:46 pmRNSResult of AGM
14th Nov 20257:01 amRNSAppointment of Non-Executive Director
14th Nov 20257:00 amRNSAGM Trading Update
6th Nov 20255:09 pmRNSDirector/PDMR Shareholding
24th Oct 20254:16 pmRNSDirector/PDMR Shareholding
23rd Oct 20255:07 pmRNSDirector/PDMR Shareholding
20th Oct 20254:09 pmRNSDirector/PDMR Shareholding
17th Oct 20257:00 amRNSNotice of AGM
7th Oct 20253:18 pmRNSDirector/PDMR Shareholding
22nd Sep 20255:01 pmRNSREPLACEMENT: Director/PDMR Shareholding
18th Sep 20257:00 amRNS-RPresentation on Engage Investor Platform
17th Sep 20254:23 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSAudited results for the year ended 30 June 2025
9th Sep 202510:45 amRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSNotice of Full-Year Results and Presentation
7th Aug 20253:05 pmRNSDirector/PDMR Shareholding
10th Jul 20254:17 pmRNSDirector/PDMR Shareholding
9th Jul 20251:05 pmRNSHolding(s) in Company
8th Jul 20254:00 pmRNSDirector/PDMR Shareholding
7th Jul 20253:11 pmRNSHolding(s) in Company
4th Jul 20257:00 amRNSDirectorate Change
4th Jul 20257:00 amRNSTrading Statement
12th Jun 20253:21 pmRNSDirector/PDMR Shareholding
10th Jun 202511:34 amRNSDirector/PDMR Shareholding
6th Jun 20257:00 amRNSHolding(s) in Company
4th Jun 20255:06 pmRNSDirector/PDMR Shareholding
3rd Jun 20257:03 amRNSTrading Update
7th May 20252:33 pmRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSDirectorate Change
8th Apr 20255:22 pmRNSDirector/PDMR Shareholding
8th Apr 20255:17 pmRNSDirector/PDMR Shareholding
6th Mar 20254:52 pmRNSDirector/PDMR Shareholding
5th Mar 20252:54 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.